Clinical Trials Logo
  1. Home
  2. Vasomotor Symptoms
  3. NCT01052454
  4. Details
NCT01052454 Clinical Trial

Mindfulness-Based Stress Reduction for Hot Flashes

Vasomotor Symptoms Clinical Trial

Official title:
Pilot Study to Assess the Feasibility of MBSR for Hot Flashes

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT01052454
Other study ID # AT002910
Secondary ID
Status Completed
Phase Phase 0
First received January 18, 2010
Last updated January 19, 2010
Start date September 2005

Study information
Verified date January 2010
Source University of Massachusetts, Worcester
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

This is a study to determine if participation in a mindfulness-based stress reduction program is feasible for women experiencing five or more hot flashes/day, and whether it affects either the frequency and/or intensity of their hot flashes, or the degree of bother they experience from them

Recruitment information / eligibility
Status Completed
Enrollment 110
Est. completion date
Est. primary completion date May 2009
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria:

- Women experiencing 5 or more hot flashes/day

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Intervention

Behavioral:
• Mindfulness-based stress reduction
Participants in the MBSR arm attend eight weekly classes.

Locations
Country Name City State
United States UMass Medical School Worcester Massachusetts

Sponsors (1)
Lead Sponsor Collaborator
University of Massachusetts, Worcester

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Hot Flash intensity/bother
See also
  Status Clinical Trial Phase
Completed NCT04090957 - Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women Phase 3
Completed NCT00535288 - Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013) Phase 3
Recruiting NCT00906308 - A Study of MF101 in Postmenopausal Women Phase 3
Completed NCT01452373 - Dehydroepiandrosterone (DHEA) + Acolbifene Against Vasomotor Symptoms (Hot Flushes) in Postmenopausal Women Phase 3
Completed NCT00560833 - Dose-Finding Safety and Efficacy Trial of Org50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (46101/P06459/MK-8265-012) Phase 3
Completed NCT05033886 - A Study of Fezolinetant to Treat Hot Flashes in Women Going Through Menopause Phase 3
Completed NCT05083884 - A Survey About Hot Flashes in Women Going Through the Menopause
Completed NCT01178892 - MsFLASH-02: Interventions for Relief of Menopausal Symptoms: A 3-by-2 Factorial Design Examining Yoga, Exercise, and Omega-3 Supplementation N/A
Completed NCT00397176 - Study Evaluating Safety, Tolerability, and PK of DVS SR in Healthy Japanese Women Phase 1
Recruiting NCT06122181 - Study of HS-10384 in Participants of Chinese Postmenopausal Women Phase 1
Not yet recruiting NCT06393673 - A Study to Find the Best Dose of HS-10384 to Treat Vasomotor Symptoms in Postmenopausal Women Phase 2
Withdrawn NCT02202707 - Vasomotor Symptoms and Cardiovascular Control N/A
Completed NCT00356447 - Safety/Efficacy Study of Drospirenone/Estradiol to Treat Postmenopausal Chinese Women With Vasomotor Symptoms. Phase 3
Completed NCT05312567 - FP-101 Versus Placebo in the Treatment of Menopausal Vasomotor Symptoms Phase 2
Terminated NCT01353963 - Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino Patients Phase 4
Completed NCT00446199 - Low-dose Hormone Therapy for Relief of Vasomotor Symptoms Phase 3
Completed NCT05850338 - Determination of the Effects of Autogenic Relaxation Exercise and Cold Pillow Application on Vasomotor Symptom Control and Quality of Life in Postmenopausal Women N/A
Completed NCT02803268 - A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of MT-8554 in Female Subjects Experiencing Vasomotor Symptoms Phase 1
Completed NCT00683800 - Study Evaluating The Safety And Efficacy Of Desvenlafaxine Succinate For Vasomotor Symptoms In Menopausal Women Phase 3
Completed NCT03512002 - HIRREM Hot Flashes Study N/A